[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]
Re: ICN Pharmaceuticals
Anyone may contact me privately at: smnemecek@icnpharm.com
or call me at 1-800-548-5100 . Thank you.
Sandi Nemecek
Director
ICN Dosimetry
ICN Plaza
3300 Hyland Avenue
Costa Mesa., CA 92626
smnemecek@icnpharm.com
subj: ICN Pharmaceuticals
Date: 3/1/00 7:54:46 AM Pacific Standard Time
From: rosen@radsafe.pitt.edu (Rosen_Jerry)
Sender: radsafe@romulus.ehs.uiuc.edu
Reply-to: radsafe@romulus.ehs.uiuc.edu
To: radsafe@romulus.ehs.uiuc.edu (Multiple recipients of list)
Reuters is carrying a press release about the "possibility" of ICN
Pharmaceuticals divesting parts of their Biomedical Division.
http://biz.yahoo.com/rf/000224/bhw.html
Has anyone heard more on this issue. I assume this would have bearing on
their radiochemicals operations as well as their dosimetry operations. The
article is not clear on whether this impacts only their Eastern European
operations or their world wide operations.
************************************************************************
The RADSAFE Frequently Asked Questions list, archives and subscription
information can be accessed at http://www.ehs.uiuc.edu/~rad/radsafe.html
************************************************************************
The RADSAFE Frequently Asked Questions list, archives and subscription
information can be accessed at http://www.ehs.uiuc.edu/~rad/radsafe.html